Exploring NCATS In-House Biomedical Data for Evidence-based Drug Repurposing

Area of Science:

• Biomedical Informatics
• Drug Discovery
• Translational Science

Background:

• Drug repurposing identifies new therapeutic indications for existing drugs.
• Historically serendipitous, drug repurposing now benefits from large-scale biomedical data.
• Systemic, data-driven approaches enhance drug candidate identification.

Conclusions:

• The integration of Tox21 and Translator data provides a powerful framework for drug repurposing.
• This data-driven strategy facilitates the systematic identification of novel therapeutic applications for existing compounds.
• Further case studies are detailed to illustrate the practical application of this methodology.